关注
Kui Shen
标题
引用次数
引用次数
年份
An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection
X Wang, DD Kang, K Shen, C Song, S Lu, LC Chang, SG Liao, Z Huo, ...
Bioinformatics 28 (19), 2534-2536, 2012
2162012
Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome
MK Jang, K Shen, AA McBride
PLoS pathogens 10 (5), e1004117, 2014
1172014
The effect of Rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional
S Chapman, DH McDermott, K Shen, MK Jang, AA McBride
Stem cell research & therapy 5, 1-11, 2014
1102014
Meta-analysis for pathway enrichment analysis when combining multiple genomic studies
K Shen, GC Tseng
Bioinformatics 26 (10), 1316-1323, 2010
1062010
Systemic cytokine profiles in Strongyloides stercoralis infection and alterations following treatment
R Anuradha, S Munisankar, Y Bhootra, J Jagannathan, C Dolla, ...
Infection and immunity 84 (2), 425-431, 2016
572016
A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever
A Marzi, L Banadyga, E Haddock, T Thomas, K Shen, EJ Horne, DP Scott, ...
Scientific reports 6 (1), 39214, 2016
502016
Lung cancer screening: from imaging to biomarker
D Xiang, B Zhang, D Doll, K Shen, G Kloecker, C Freter
Biomarker research 1, 1-10, 2013
492013
Prognostic significance of liver metastasis in durvalumab-treated lung cancer patients
S Sridhar, L Paz-Ares, H Liu, K Shen, C Morehouse, N Rizvi, NH Segal, ...
Clinical Lung Cancer 20 (6), e601-e608, 2019
472019
Biomarker detection in the integration of multiple multi-class genomic studies
S Lu, J Li, C Song, K Shen, GC Tseng
Bioinformatics 26 (3), 333-340, 2010
452010
On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors
F Morschhauser, JP Machiels, G Salles, S Rottey, SAJ Rule, ...
Molecular cancer therapeutics 19 (2), 468-478, 2020
402020
In depth annotation of the Anopheles gambiae mosquito midgut transcriptome
A Padron, A Molina-Cruz, M Quinones, JMC Ribeiro, U Ramphul, ...
BMC genomics 15, 1-14, 2014
402014
Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trial
K Shen, Y Qi, N Song, C Tian, SD Rice, MJ Gabrin, SL Brower, ...
BMC medical genomics 5, 1-8, 2012
392012
Modulation of pro-and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infection
PJ George, NP Kumar, J Jaganathan, C Dolla, P Kumaran, D Nair, ...
Tuberculosis 95 (6), 822-828, 2015
282015
Ratio adjustment and calibration scheme for gene-wise normalization to enhance microarray inter-study prediction
C Cheng, K Shen, C Song, J Luo, GC Tseng
Bioinformatics 25 (13), 1655-1661, 2009
282009
Global selective sweep of a highly inbred genome of the cattle parasite Neospora caninum
A Khan, AW Fujita, N Randle, J Regidor-Cerrillo, JS Shaik, K Shen, ...
Proceedings of the National Academy of Sciences 116 (45), 22764-22773, 2019
272019
Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines
K Shen, SD Rice, DA Gingrich, D Wang, Z Mi, C Tian, Z Ding, SL Brower, ...
PloS one 7 (7), e40900, 2012
252012
A systematic evaluation of multi-gene predictors for the pathological response of breast cancer patients to chemotherapy
K Shen, N Song, Y Kim, C Tian, SD Rice, MJ Gabrin, WF Symmans, ...
PloS one 7 (11), e49529, 2012
242012
Kissing-loop interaction between 5′ and 3′ ends of tick-borne Langat virus genome ‘bridges the gap’between mosquito-and tick-borne flaviviruses in mechanisms of viral RNA …
KA Tsetsarkin, G Liu, K Shen, AG Pletnev
Nucleic acids research 44 (7), 3330-3350, 2016
222016
Analysis of chemotherapeutic response heterogeneity and drug clustering based on mechanism of action using an in vitro assay
SD Rice, JM Heinzman, SL Brower, PR Ervin, N Song, K Shen, D Wang
Anticancer research 30 (7), 2805-2811, 2010
212010
Association of liver metastases (LM) with survival in NSCLC patients treated with durvalumab (D) in two independent clinical trials.
LG Paz-Ares, K Shen, BW Higgs, C Morehouse, NA Rizvi, NH Segal, X Jin, ...
Journal of Clinical Oncology 35 (15_suppl), 3038-3038, 2017
122017
系统目前无法执行此操作,请稍后再试。
文章 1–20